PeptideDB

p53 and MDM2 proteins-interaction-inhibitor chiral 939981-37-0

p53 and MDM2 proteins-interaction-inhibitor chiral 939981-37-0

CAS No.: 939981-37-0

Chiral p53 and MDM2 proteins-interaction-inhibitor is an inhibitor (blocker/antagonist) of the interaction between p53 a
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Chiral p53 and MDM2 proteins-interaction-inhibitor is an inhibitor (blocker/antagonist) of the interaction between p53 and MDM2.

Physicochemical Properties


Molecular Formula C40H49N5O4CL2
Molecular Weight 734.75416
Exact Mass 733.316
CAS # 939981-37-0
Related CAS # p53 and MDM2 proteins-interaction-inhibitor dihydrochloride;2070009-27-5;p53 and MDM2 proteins-interaction-inhibitor (racemic);939983-14-9
PubChem CID 17754765
Appearance White to off-white solid powder
Density 1.24g/cm3
Boiling Point 788.563ºC at 760 mmHg
Flash Point 430.708ºC
LogP 6.366
Hydrogen Bond Donor Count 0
Hydrogen Bond Acceptor Count 6
Rotatable Bond Count 8
Heavy Atom Count 51
Complexity 1230
Defined Atom Stereocenter Count 2
SMILES

CCOC1=C(C=CC(=C1)C(C)(C)C)C2=N[C@@]([C@@](N2C(=O)N3CCN(CC3)CC(=O)N4CCOCC4)(C)C5=CC=C(C=C5)Cl)(C)C6=CC=C(C=C6)Cl

InChi Key DJZBZZRLUQDRII-IOLBBIBUSA-N
InChi Code

InChI=1S/C40H49Cl2N5O4/c1-7-51-34-26-30(38(2,3)4)12-17-33(34)36-43-39(5,28-8-13-31(41)14-9-28)40(6,29-10-15-32(42)16-11-29)47(36)37(49)46-20-18-44(19-21-46)27-35(48)45-22-24-50-25-23-45/h8-17,26H,7,18-25,27H2,1-6H3/t39-,40+/m0/s1
Chemical Name

2-[4-[(4S,5R)-2-(4-tert-butyl-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dimethylimidazole-1-carbonyl]piperazin-1-yl]-1-morpholin-4-ylethanone
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


References

[1]. A Fusion Protein of the p53 Transaction Domain and the p53-Binding Domain of the Oncoprotein MdmX as an Efficient System for High-Throughput Screening of MdmX Inhibitors. Biochemistry. 2017 Jun 27;56(25):3273-3282.


Solubility Data


Solubility (In Vitro) DMSO : ~50 mg/mL (~68.05 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 3.25 mg/mL (4.42 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 32.5 mg/mL clear DMSO stock solution to 400 μL of PEG300 and mix evenly; then add 50 μL of Tween-80 to the above solution and mix evenly; then add 450 μL of normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 3.25 mg/mL (4.42 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 32.5 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 1.3610 mL 6.8050 mL 13.6101 mL
5 mM 0.2722 mL 1.3610 mL 2.7220 mL
10 mM 0.1361 mL 0.6805 mL 1.3610 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.